Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension
Antioxidants · 26.04.2023 · 12 (5) · 1006
DOI: 10.3390/antiox12051006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 26.04.2023. Verfasst von Paula Poyatos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research …. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, University of Girona, Servicio Público de Empleo Estatal.
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a progressive disease characterized by elevated artery pressures and pulmonary vascular resistance. Underlying mechanisms comprise endothelial dysfunction, pulmonary artery remodeling and vasoconstriction. Several studies have shown evidence of the critical role of oxidative stress in PH pathophysiology. Alteration of redox homeostasis produces excessive generation of reactive oxygen species, inducing oxidative stress and the subsequent alteration of biological molecules. Exacerbations in oxidative stress production can lead to alterations in nitric oxide signaling pathways, contributing to the proliferation of pulmonary arterial endothelial cells and smooth muscle cells, inducing PH development. Recently, antioxidant therapy has been suggested as a novel therapeutic strategy for PH pathology. However, the favorable outcomes observed in preclinical studies have not been consistently reproduced in clinical practice. Therefore, targeting oxidative stress as a therapeutic intervention for PH is an area that is still being explored. This review summarizes the contribution of oxidative stress to the pathogenesis of the different types of PH and suggests antioxidant therapy as a promising strategy for PH treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190 Girona, Spain.
- Department of Medical Sciences, Faculty of Medicine, University of Girona, 17003 Girona, Spain.
- Scottish National Blood Transfusion Service, NHS National Services Scotland, Edinburgh EH14 4BE, UK.
- Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), 28029 Madrid, Spain.
ORCID-Profile: Paula Poyatos, Miquel Gratacós
Förderung
- Instituto de Salud Carlos III
- University of Girona
- Servicio Público de Empleo Estatal
- Institute of Health Carlos III
- European Union, FEDER “Una manera de hacer Europa”
- Banco Santander-University of Girona
- Investigo
- SEPE
Zitieren
APA
Poyatos, P., Gratacós, M., Samuel, K., Orriols, R., & Tura-Ceide, O. (2023). Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension. Antioxidants, 12(5), 1006. https://doi.org/10.3390/antiox12051006
Vancouver
Poyatos P, Gratacós M, Samuel K, Orriols R, Tura-Ceide O. Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension. Antioxidants. 2023;12(5):1006. doi:10.3390/antiox12051006
BibTeX
@article{Poyatos2023,
author = {Poyatos, Paula and Gratacós, Miquel and Samuel, Kay and Orriols, Ramon and Tura-Ceide, Olga},
title = {Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {5},
pages = {1006},
doi = {10.3390/antiox12051006}
}
EUVIMED